Brief: Dr. Lal Pathlabs Says NCLT Sanctioned Scheme Of Amalgamation Between Co And APL Institute Of Clinical Laboratory & Research
17/03/2023 14:30
March 17 (Reuters) - Dr. Lal PathLabs Ltd DLPA.NS :
* NCLT SANCTIONED SCHEME OF AMALGAMATION BETWEEN CO AND APL
INSTITUTE OF CLINICAL LABORATORY & RESEARCH
Source text for Eikon: ID:nNSE4fhTn1
Further company coverage: DLPA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dr. Lal PathLabs
See all newsBrief: Lal Pathlabs Says Unit Acquired Remaining 30% Equity Stake In Centrapath Labs Private Limited
India's Dr Lal PathLabs rises as Axis Securities initiates with 'buy'
India's Dr Lal PathLabs rises; analysts back SN Genelab deal
Brief: Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan
India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise